A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings published in Molecular Cell uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases.
Discovery of mechanics of drug targets for COVID-19
September 28, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022